From Notable Calls

Arena Pharmaceuticals (NASDAQ: ARNA) is getting surprisingly positive comments from several firms after the FDA’s Endocrinologic and Metabolic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE